These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 2967290)
41. Amplification and organization of dihydrofolate reductase genes in a human leukemic cell line, K-562, resistant to methotrexate. Srimatkandada S; Medina WD; Cashmore AR; Whyte W; Engel D; Moroson BA; Franco CT; Dube SK; Bertino JR Biochemistry; 1983 Dec; 22(25):5774-81. PubMed ID: 6661412 [TBL] [Abstract][Full Text] [Related]
42. [Methotrexate and its drug resistance]. Nagura E Gan To Kagaku Ryoho; 1988 Oct; 15(10):2882-7. PubMed ID: 3178237 [TBL] [Abstract][Full Text] [Related]
43. Molecular mechanisms of resistance to antifolates, a review. Banerjee D; Ercikan-Abali E; Waltham M; Schnieders B; Hochhauser D; Li WW; Fan J; Gorlick R; Goker E; Bertino JR Acta Biochim Pol; 1995; 42(4):457-64. PubMed ID: 8852336 [TBL] [Abstract][Full Text] [Related]
44. Maintenance of differential methotrexate toxicity between cells expressing drug-resistant and wild-type dihydrofolate reductase activities in the presence of nucleosides through nucleoside transport inhibition. Warlick CA; Sweeney CL; McIvor RS Biochem Pharmacol; 2000 Jan; 59(2):141-51. PubMed ID: 10810448 [TBL] [Abstract][Full Text] [Related]
45. Dihydrofolate Reductase and Thymidylate Synthase Transgenes Resistant to Methotrexate Interact to Permit Novel Transgene Regulation. Rushworth D; Mathews A; Alpert A; Cooper LJ J Biol Chem; 2015 Sep; 290(38):22970-6. PubMed ID: 26242737 [TBL] [Abstract][Full Text] [Related]
46. Dihydrofolate reductase amplification and sensitization to methotrexate of methotrexate-resistant colon cancer cells. Morales C; García MJ; Ribas M; Miró R; Muñoz M; Caldas C; Peinado MA Mol Cancer Ther; 2009 Feb; 8(2):424-32. PubMed ID: 19190117 [TBL] [Abstract][Full Text] [Related]
47. Polyoma virus and cyclic AMP-mediated control of dihydrofolate reductase mRNA abundance in methotrexate-resistant mouse fibroblasts. Kellems RE; Morhenn VB; Pfendt EA; Alt FW; Schimke RT J Biol Chem; 1979 Jan; 254(2):309-18. PubMed ID: 216671 [TBL] [Abstract][Full Text] [Related]
48. Antifolate polyglutamylation and competitive drug displacement at dihydrofolate reductase as important elements in leucovorin rescue in L1210 cells. Matherly LH; Barlowe CK; Goldman ID Cancer Res; 1986 Feb; 46(2):588-93. PubMed ID: 2416428 [TBL] [Abstract][Full Text] [Related]
49. Retroviral coexpression of thymidylate synthase and dihydrofolate reductase confers fluoropyrimidine and antifolate resistance. Fantz CR; Shaw D; Moore JG; Spencer HT Biochem Biophys Res Commun; 1998 Feb; 243(1):6-12. PubMed ID: 9473470 [TBL] [Abstract][Full Text] [Related]
50. Immunologic heterogeneity of dihydrofolate reductase from methotrexate sensitive and resistant L1210 leukemia cells. Iqbal MP; Rothenberg SP; Larosa C Proc Soc Exp Biol Med; 1985 Oct; 180(1):98-102. PubMed ID: 2412235 [TBL] [Abstract][Full Text] [Related]
51. Membrane protein changes in an L1210 leukemia cell line with a translocation defect in the methotrexate-tetrahydrofolate cofactor transport carrier. Schuetz JD; Westin EH; Matherly LH; Pincus R; Swerdlow PS; Goldman ID J Biol Chem; 1989 Sep; 264(27):16261-7. PubMed ID: 2777791 [TBL] [Abstract][Full Text] [Related]
52. The role of folates in the development of methotrexate resistance in human leukemia cell line K562. Miyachi H; Takemura Y; Ando Y; Scanlon KJ J Cancer Res Clin Oncol; 1992; 119(2):101-5. PubMed ID: 1429825 [TBL] [Abstract][Full Text] [Related]
53. Quantitative correlation of homogeneously stained regions on chromosome 10 with dihydrofolate reductase enzyme in human cells. Wolman SR; Craven ML; Grill SP; Domin BA; Cheng YC Proc Natl Acad Sci U S A; 1983 Feb; 80(3):807-9. PubMed ID: 6572370 [TBL] [Abstract][Full Text] [Related]
54. Investigations on the mechanisms of methotrexate resistance in a cisplatin-resistant L1210 murine leukemia cell subline. Wroblewski DH; Bhushan A; Xuan Y; Brinton BT; Tritton TR; Hacker MP Cancer Chemother Pharmacol; 1996; 37(4):337-42. PubMed ID: 8548879 [TBL] [Abstract][Full Text] [Related]
55. Dihydrofolate reductase activity in adriamycin and methotrexate sensitive and resistant P388 leukemia cells. Mandelbaum-Shavit F; Ramu A Cell Biol Int Rep; 1987 May; 11(5):389-96. PubMed ID: 3607890 [TBL] [Abstract][Full Text] [Related]
57. A possible role for topoisomerase II in cell death and N-phosphonoacetyl-L-aspartate-resistance frequency and its enhancement by 1-beta-D-arabinofuranosyl cytosine and 5-fluoro-2'-deoxyuridine. Goz B; Bastow KF Mutat Res; 1997 Aug; 384(2):89-106. PubMed ID: 9298118 [TBL] [Abstract][Full Text] [Related]
58. Synthesis of methotrexate polyglutamates in L1210 murine leukemia cells. Whitehead VM Cancer Res; 1977 Feb; 37(2):408-12. PubMed ID: 832265 [TBL] [Abstract][Full Text] [Related]
59. [Localization of dihydrofolate reductase amplified genes in Chinese hamster cells resistant to methotrexate]. Mukhamedkhanova FS; Kuznetsova NN; Nuridzhaniants SS; Abdurkarimov AA Genetika; 1987 Sep; 23(9):1588-94. PubMed ID: 3692154 [TBL] [Abstract][Full Text] [Related]
60. Amplification of the dihydrofolate reductase gene is a mechanism of acquired resistance to methotrexate in patients with acute lymphoblastic leukemia and is correlated with p53 gene mutations. Göker E; Waltham M; Kheradpour A; Trippett T; Mazumdar M; Elisseyeff Y; Schnieders B; Steinherz P; Tan C; Berman E Blood; 1995 Jul; 86(2):677-84. PubMed ID: 7605998 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]